Help
RSS
API
Feed
Maltego
Contact
Domain > nuplazid.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2016-04-29
54.230.15.120
(
ClassC
)
2021-11-30
44.240.223.212
(
ClassC
)
2024-12-23
104.26.1.54
(
ClassC
)
2025-06-21
104.26.0.54
(
ClassC
)
2026-01-25
172.67.71.54
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyDate: Mon, 15 Jan 2024 19:25:27 GMTContent-Type: text/html; charsetiso-8859-1Transfer-Encoding: chunkedConnection: keep-aliveLocation: https://nuplazid.com/CF-Cache-Statu !DOCTYPE HTML PUBLIC -//IETF//DTD HTML 2.0//EN>html>head>title>301 Moved Permanently/title>/head>body>h1>Moved Permanently/h1>p>The document has moved a hrefhttps://nuplazid.com/>here/a>./p>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Mon, 15 Jan 2024 19:25:27 GMTContent-Type: text/html; charsetUTF-8Transfer-Encoding: chunkedConnection: keep-alivex-ua-compatible: IEedgex-ua-compatible: IEedgex-content-type-opti !DOCTYPE html>html langen>head> script> (function(w, d, s, l, i) { wl wl || ; wl.push({ gtm.start: new Date().getTime(), event: gtm.js }); var f d.getElementsByTagName(s)0, j d.createElement(s), dl l ! dataLayer ? &l + l : ; j.async true; j.src https://www.googletagmanager.com/gtm.js?id + i + dl; f.parentNode.insertBefore(j, f); })(window, document, script, dataLayer, GTM-5MPHMB); /script> meta charsetutf-8> meta nameviewport contentwidthdevice-width, initial-scale1, shrink-to-fitno> meta namedescription contentNUPLAZID® is the only FDA approved treatment for hallucinations and delusions associated with PD psychosis. See Important Safety Information and Full Prescribing Information, including Boxed WARNING.> title>Parkinson's-Related Hallucinations and Delusions Treatment | NUPLAZID® (pimavanserin)/title> meta propertyog:type contentwebsite /> meta propertyog:title contentParkinson's-Related Hallucinations and Delusions Treatment | NUPLAZID® (pimavanserin) /> meta propertyog:description contentNUPLAZID® is the only FDA approved treatment for hallucinations & delusions associated with PD psychosis. See Important Safety Information & Full Prescribing Information including Boxed WARNING. /> meta propertyog:url contenthttps://www.nuplazid.com/ /> script typeapplication/ld+json> { @context: http://schema.org/, @type: Drug, alternateName: pimavanserin, description: NUPLAZID is an FDA-approved treatment for hallucinations and delusions associated with Parkinsons disease psychosis., manufacturer: Acadia Pharmaceuticals Inc., name: NUPLAZID, url: https://www.nuplazid.com, warning: INCREASED RISK OF DEATH IN ELDERLY PATIENTS WITH DEMENTIA–RELATED PSYCHOSIS. Medicines like NUPLAZID can raise the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia). NUPLAZID is not
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]